ClinicalTrials.gg
CompletedNCT03342508Updated Sep 19, 2019

Fetal Pillow Randomized Controlled Trial

An interventional study of Fetal Pillow in Labor Complication, sponsored by Brigham and Women's Hospital. Completed at 1 site in United States. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-09-19.

Sponsored by Brigham and Women's Hospital · Not applicable, Interventional, and Prevention

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 26 studies in Obstetric Labor Complications with a site in United States — 9 open to participants now, 9 under way, none of them phase 3. Obstetric Labor Complications · United States.

Enrollment
15th of 20
60 · median 95
Started
2018
with 1 other
No phase
14 of 26
4 open now
Registered
6th of 26
by date
Lead sponsor
1 of 26
Brigham and Women's Hospital

Among the 26 studies in Obstetric Labor Complications with a site in United States, this one is the 15th largest by enrollment of the 20 interventional ones that give a count, is one of 2 that started in 2018, is one of 14 with no phase, and was the 6th registered.

Obstetric Labor Complications

88 studies on the registry are indexed under Obstetric Labor Complications; 24 are open to participants now.

Browse Obstetric Labor Complications studies →

Open to participants now

9 of the 26 studies in Obstetric Labor Complications with a site in United States are open now. Recruiting first, the newest first:

4 more — sign in →

All 9 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 18 Obstetric Labor Complications studies recruiting now, 7 (39%) set no upper age limit and 9 (50%) stop at 75 or younger; 4 take children under 18; 11 take healthy volunteers.

This study: 18 Years to 50 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 26 studies in Obstetric Labor Complications with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to evaluate outcomes following cesarean delivery for failure to progress with the use of the Fetal Pillow. Our hypothesis is that time to delivery of the fetus is shorter with implementation of the Fetal Pillow.

Read the detailed description

Women will be enrolled from the labor floor during their labor course when there is concern for cesarean section for failure to progress in the second stage of labor. These women may be approached if they have a prolonged labor course (before they reach full dilation), when they get to full dilation and start pushing, or following an unsuccessful operative delivery. All women who meet the inclusion criteria will be approached about participation in the study on labor and delivery. The process of informed consent will happen at that time on labor and delivery. All women will be enrolled by study staff or certain physicians at Brigham and Women's Hospital who have agreed to help consent patients for this study.

Once consent is obtained, the subjects will then be randomized 1:1 into two parallel groups, the Fetal Pillow Inflated (FPI) group and the Fetal Pillow Not Inflated (FPNI) group. A random number generator will allocate the groups in blocks of ten.

The Fetal Pillows used in the study have been donated by Safe Obstetrics Systems.

Each patient will have a Fetal Pillow inserted vaginally by the obstetrician after catheterization of the bladder (if it has not been previously performed). Once the Fetal Pillow is in place, the woman's legs will be placed flat on the operating table. The anesthesiologist will then inflate the Fetal Pillow if the patient has been randomized into the Fetal Pillow Inflated (FPI) group. In the Fetal Pillow Not Inflated (FPNI) group, the device will remain, not inflated, in the vagina. The obstetrician will therefore be blinded to the intervention. In the FPNI group the obstetrician will continue to be able to use conventional methods for delivery of a second stage arrest including hand from below and reverse breech extraction. The Fetal Pillow will be drained by the circulating nurse in the operating room following delivery with removal at the end of the procedure by the obstetrician.

03

Conditions studied

  • Labor Complication

Keywords

  • Maternal outcomes
  • Neonatal Outcomes
04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • women age 18-50
  • term pregnancy (37- 41 6/7 weeks)
  • singleton gestation in cephalic presentation
  • fully dilated
  • both nulliparous and multiparous women
  • both spontaneous labor and labor inductions

Exclusion criteria

Exclusion Criteria:

  • breech presentation
  • presence of to vaginal delivery
  • prior cesarean section
  • presence of congenital anomalies
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Fetal Pillow Inflated (FPI)

    A Fetal Pillow will be inserted vaginally by the obstetrician after catheterization of the bladder (if it has not been previously performed). Once the Fetal Pillow is in place, the woman's legs will be placed flat on the operating table. The anesthesiologist will then inflate the Fetal Pillow. The obstetrician will not be aware to inflation of Fetal Pillow Cesarean delivery will then be performed The circulating nurse will deflate the Fetal Pillow following delivery. The obstetrician will remove the Fetal Pillow at the end of the procedure. The obstetrician will then fill out a survey regarding the delivery.

    Device: Fetal Pillow

  • No intervention
    Fetal Pillow Not Inflated (FPNI)

    A Fetal Pillow will be inserted vaginally by the obstetrician after catheterization of the bladder (if it has not been previously performed). Once the Fetal Pillow is in place, the woman's legs will be placed flat on the operating table. The Fetal Pillow will not be inflated. Cesarean delivery will then be performed. The obstetrician will continue to be able to use conventional methods for delivery of a second stage arrest including hand from below and reverse breech extraction. The circulating nurse will deflate the Fetal Pillow following delivery. The obstetrician will remove the Fetal Pillow at the end of the procedure. The obstetrician will then fill out a survey regarding the delivery.

Interventions

  • DeviceFetal Pillow

    see arm description

06

What researchers measure

Primary outcomes

  1. Uterine incision to delivery time

    Time (in seconds) from hysterotomy to delivery

    Time frame: Assessed at time of delivery, delivery day (day 0)

Secondary outcomes

  1. Difficulty of Delivery of Fetal head

    Score of difficulty of delivery 1-5 (1: very difficult, 5: very easy)

    Time frame: Assessed at time of delivery, delivery day (day 0)

  2. Uterine extension

    Grading of extension 1-3

    Time frame: Assessed at time of delivery, delivery day (day 0)

  3. Composite Maternal Morbidity

    Blood loss, presence of blood transfusion, change in hematocrit from preop to postop day 1, temperature\>100.4, ICU transfer, presence of Disseminated intravascular coagulation (DIC), readmission

    Time frame: Assessed both following delivery (day 0) and at end of study period (week 4)

  4. Length of stay

    Maternal Length of stay

    Time frame: Assessed at end of study period (week 4)

  5. Fetal Weight

    Weight of fetus at time of birth

    Time frame: Assessed at time of delivery, delivery day (day 0)

  6. 1 minute APGAR

    Assessment of the 1 minute APGAR

    Time frame: Assessed at time of delivery, delivery day (day 0)

  7. 5 minute APGAR

    Assessment of the 5 minute APGAR

    Time frame: Assessed at time of delivery, delivery day (day 0)

  8. Composite Neonatal Morbidity

    Need for intubation, fetal trauma

    Time frame: Assessed at end of study period (week 4)

  9. Neonatal Intensive Care Unit (NICU) Length of Stay

    Length of stay in NICU

    Time frame: Assessed at end of study period (week 4)

  10. Provider Opinions

    Willingness to recommend to others based on ease of placement and removal (1-5 point scale)

    Time frame: Assessed at end of study period (week 4)

07

Study locations

1 site
  • Brigham and Women's Hospital
    Boston, Massachusetts 02115, United States
08

References and documents

Publications

  • Mancuso MS, Rouse DJ. Cesarean delivery for abnormal labor. Clin Perinatol. 2008 Sep;35(3):479-90, ix. doi: 10.1016/j.clp.2008.06.004. PubMed 18952016 ↗
  • Myles TD, Santolaya J. Maternal and neonatal outcomes in patients with a prolonged second stage of labor. Obstet Gynecol. 2003 Jul;102(1):52-8. doi: 10.1016/s0029-7844(03)00400-9. PubMed 12850607 ↗
  • Safa H, Beckmann M. Comparison of maternal and neonatal outcomes from full-dilatation cesarean deliveries using the Fetal Pillow or hand-push method. Int J Gynaecol Obstet. 2016 Dec;135(3):281-284. doi: 10.1016/j.ijgo.2016.06.013. Epub 2016 Aug 24. PubMed 27599604 ↗
  • Seal SL, Dey A, Barman SC, Kamilya G, Mukherji J. Does elevating the fetal head prior to delivery using a fetal pillow reduce maternal and fetal complications in a full dilatation caesarean section? A prospective study with historical controls. J Obstet Gynaecol. 2014 Apr;34(3):241-4. doi: 10.3109/01443615.2013.844108. Epub 2014 Jan 31. PubMed 24483234 ↗
  • Seal SL, Dey A, Barman SC, Kamilya G, Mukherji J, Onwude JL. Randomized controlled trial of elevation of the fetal head with a fetal pillow during cesarean delivery at full cervical dilatation. Int J Gynaecol Obstet. 2016 May;133(2):178-82. doi: 10.1016/j.ijgo.2015.09.019. Epub 2016 Jan 15. Erratum In: Int J Gynaecol Obstet. 2023 Apr;161(1):333. doi: 10.1002/ijgo.14664. PubMed 26868074 ↗
  • Lassey SC, Little SE, Saadeh M, Patton N, Farber MK, Bateman BT, Robinson JN. Cephalic Elevation Device for Second-Stage Cesarean Delivery: A Randomized Controlled Trial. Obstet Gynecol. 2020 Apr;135(4):879-884. doi: 10.1097/AOG.0000000000003746. PubMed 32168216 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2018 to primary completion in Aug 2019, 18 months.

Of 27 interventional studies with no phase under Obstetric Labor Complications, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 51. This study's 18 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 8, 2017
First posted
Nov 17, 2017
StartActual
Jan 13, 2018
Primary completionActual
Aug 1, 2019
CompletionActual
Aug 1, 2019
Last update
Sep 19, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 19, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03342508
Responsible party
Julian N Robinson (Principal Investigator, Brigham and Women's Hospital) — Principal investigator
First posted
Nov 17, 2017
Start date
Jan 13, 2018
Primary completion
Aug 1, 2019
Completion
Aug 1, 2019
Last update
Sep 19, 2019

Study contacts

Julian N Robinson, MD
principal investigator · Brigham and Women's Hospital, Harvard Medical School, Boston MA

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion